Cargando…
Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
Adoptive cell therapy (ACT) is a kind of immunotherapy in which T cells are genetically modified to express a chimeric antigen receptor (CAR) or T cell receptor (TCR), and ACT has made a great difference in treating multiple types of tumors. ACT is not perfect, and it can be followed by severe side...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066210/ https://www.ncbi.nlm.nih.gov/pubmed/32194541 http://dx.doi.org/10.3389/fimmu.2020.00176 |